Latest Stent Stories
TEL AVIV, Israel, November 5, 2012 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (OTC: NSPR) announced today that the randomized 432-patient MASTER trial of its embolic protective MGuard stent will be published in the November 6, 2012 print edition of the peer-reviewed Journal of American College of Cardiology, Vol. 60, No. 19. The online version of the paper, authored by Gregg W. Stone, MD and others, appeared a week ago Wednesday (October 24) at:...
BILLERICA, Mass., Nov. 1, 2012 /PRNewswire/ -- SRS Medical announces the acquisition of The Spanner Temporary Prostatic Stent from AbbeyMoor Medical of Parkers Prairie, MN. The Spanner is FDA cleared, CE-marked, has a dedicated CPT code and is protected by patents worldwide. SRS is manufacturing The Spanner in the United States and distributing it worldwide through a hybrid distribution model of employed and brokerage representation. "The Spanner is a synergistic addition to our...
HELMOND, The Netherlands, October 30, 2012 /PRNewswire/ -- Innovator in the treatment of vascular diseases launches non compliant DEB worldwide Blue Medical, the global medical device company and innovator in the treatment of vascular diseases, today announced receiving the CE mark for Protege NC, a non compliant drug eluting balloon. The new device will be launched worldwide. It follows the introduction of Blue Medical's CE marked Drug Eluting Balloon Protege and CoCr...
Nitinol stent performs better than balloon angioplasty alone in treating lesions of the popliteal artery A study found that a nitinol stent performed better than balloon angioplasty alone in treating blockages of the popliteal artery, which runs through the leg behind the knee. Results of the ETAP trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's...
Second generation drug-eluting stents are safe and effective in treatment of left main coronary artery disease A study found that second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions. Results of the ISAR-LEFT MAIN 2 trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting...
Results of the MASTER trial reported at TCT 2012 and published in JACC A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty. Results of the MASTER trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and will appear in...
MIAMI, October 24, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC: NSPR) ("InspireMD" or the "Company"), announced its proprietary MGuard(TM) Embolic Protection Stent (EPS) was shown to be significantly superior when compared to standard bare metal and drug eluting stents in achieving complete ST resolution and restoring normal blood flow in a major study of 432 randomized patients undergoing emergency coronary intervention for potentially fatal heart attacks. The data was...
NATICK, Mass., Oct. 24, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has received approval to update the directions for use (DFU) labeling for PROMUS Element(TM) and PROMUS Element(TM) Plus Coronary Stent Systems to include three-month Dual Anti-Platelet Therapy (DAPT). This language outlines a minimum duration of three months of DAPT for certain patients who may need to interrupt or discontinue the medication for a variety of reasons and supports the strong safety...
DURHAM, N.C., Oct. 23, 2012 /PRNewswire/ -- Micell Technologies, Inc. today announced positive data from two clinical studies of its investigational MiStent(®) Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(TM)), a thin-strut drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating designed to control drug release. Eighteen-month outcomes from the DESSOLVE I trial, and nine-month data supporting all study endpoints in the DESSOLVE II...
ALBANY, New York, October 23, 2012 /PRNewswire/ -- New Market Research Report Added in MarketResearchReports.Biz Reports Database Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers [http://www.marketresearchreports.biz/analysis/143284 ] GBI Researchs [http://www.marketresearchreports.biz/publisher/2 ] report, Peripheral Vascular Devices Market to 2018...
Latest Stent Reference Libraries
Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...
